Last update 05 Jul 2025

E-2082

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
E 2082
Target
AMPA receptor
Action
antagonists
Mechanism
AMPA receptor antagonists(Glutamate receptor ionotropic AMPA antagonists)
Therapeutic Areas
Nervous System DiseasesOther Diseases
Active Indication-
Inactive Indication
Epilepsy, Reflex
Originator Organization
Eisai Co., Ltd.Eisai Co., Ltd.
Active Organization-
Inactive Organization
Eisai, Inc.Eisai, Inc.Eisai Co., Ltd.Eisai Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with E-2082
NCT03686033
/ TerminatedPhase 2
A Multicenter, Double-Blind, Randomized, Crossover, Single-Dose Study With An Open-Label Treatment Period Evaluating Pharmacodynamic Activity of E2082 in Adult Subjects With Photosensitive Epilepsy
NCT03402178
/ TerminatedPhase 1
A Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Studies to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects
100 Clinical Results associated with E-2082
Login to view more data
100 Translational Medicine associated with E-2082
Login to view more data
100 Patents (Medical) associated with E-2082
Login to view more data
100 Deals associated with E-2082
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Epilepsy, ReflexPhase 2
United States
Eisai, Inc.Eisai, Inc.
31 Oct 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03686033 (CTgov)
Phase 2
Epilepsy, Reflex
8
placebo+E2082
(Treatment A: Placebo)
fvrcfqscll(ayjdueyduv) = epyftxxiiy hkxirnjnbf (rrztvqrvng, 4.604)
View more
-
28 Sep 2020
(Treatment B: E2082 2.5 mg)
fvrcfqscll(ayjdueyduv) = isejteswvq hkxirnjnbf (rrztvqrvng, 4.336)
View more
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free